Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
The product will be launched by NATCO's commercial partner Viatris.
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Subscribe To Our Newsletter & Stay Updated
